Anda di halaman 1dari 3

DAFTAR PUSTAKA

1. Khoiriah N. 2011. Optimalisasi Pencegahan Transmisi Vertikal HIV/AIDS Dengan


Ekstrak Banlec Pada Pisang. Diunduh dari: http://kesehatan.kompasiana.com/ibudananak/2011/02/21/optimalisasi-pencegahantransmisivertikal-hivaidsdenganekstrak-banlec-pada-pisang. [diakses pada tanggal 9 April 2016]
2. Dinkes Provinsi Sumsel. 2011. Profil Kesehatan Provinsi Sumsel Tahun 2010.
Palembang: Dinkes Prov.Sumsel.
3. Stebbing J, Gazzard B, Douek DC. 2004. Where does HIV live? N Engl J Med. 2004;
350:1872-1880.
4. Departemen Kesehatan RI. 2012. Laporan Triwulan Situasi Perkembangan HIV-AIDS
di Indonesia sampai dengan Maret 2012. Jakarta.
5. Azikin R. 2009. Implementasi Tugas-Tugas Pokok Komisi Penanggulangan
Acquired

Immune

Defiency

Syndrome

(AIDS)

Daerah

(KPAD)

Dalam

Penanggulangan HIV/AIDS di Kabupaten Grobogan Tahun 2009.


6. Djoerban Z, Djauzi S. 2009. HIV/AIDS di Indonesia. Dalam: Sudoyo A, Setiyohadi B,
Alwi I, Simadibrata M, Setiati S, editors. Buku Ajar Ilmu Penyakit Dalam Edisi
kelima. Jakarta: Pusat Penerbitan IPD FKUI; p. 2861-70.
7. Pusat Data dan Informasi Departemen Kesehatan RI. 2007. Situasi HIV/AIDS di
Indonesia Tahun 1987-2006. Jakarta.
8. Schlunger NW. 2005. The Pathogenesis of Tuberculosis. Am J Respir Cell Mol Biol.
2005; 32:251-256.
9. Ravinglione MC, OBrien R. 2005. Tuberculosis. Dalam: Kasper DL, Braunwald E,
Fauci AS, Hauser SL, Longo DL, Jameson JL, editor. Harrisons Principles of
Internal Medicine Edisi keenam belas. New York: McGraw-Hill.
10. Baratawidjaya KG. 2009. Imunologi Dasar Edisi Kedelapan. Jakarta: Balai Penerbit
Fakultas Kedokteran Universitas Indonesia.
11. Raja A. 2004. Immunology of tuberculosis. Indian J Med Res. 2004; (120): 213-32.
12. WHO. 2011. Global Tuberculosis Control: WHO Report 2011. Geneva.
13. Schlunger NW, Rom WN. 1998. The Host Immune Response to Tuberculosis. Am J
Respir Crit Care Med. 1998; 157:679-691.
14. Hoshino Y, Hoshino S, Gold JA, dkk. 2007. Mechanisms of Polymorphonuclwar
Neutrophil-mediated Induction of HIV-replication in Macrophages during Pulmonary
Tuberculosis. The Journal od Infectious Diseases 2007; 195: 1303-10.
15. Equils O, Shapiro A, Madak Z, Liu C, Lu D. 2004. Human immunodeficiency Virus
type 1 Protease Inhibitors block toll-like receptor 2 (TLR2)- and TLR4-induced NFkB
activation. Antimicrobial agent and Chemotherapy. 2004: 3905-3911.
33

34

16. Tuberculosis Coalition for Technical Assistance. Tuberculosis Coalition for Technical
Assistance, International Standards for Tuberculosis Care (ISTC). 2006. The Hague.
17. Anonym. Referat HIV/AIDS. Dapat diunduh pada:
http://www.qitepscience.org/resources/artikel/REFERATHIVAIDS.pdf. [diakses pada
tanggal 9 April 2016].
18. Anonym. Informasi Dasar HIV/AIDS. 2011. Dapat diunduh pada:
http://aidsina.org/modules.php?name=FAQ&myfaq=yes&id_cat=1&categories=HIVAIDS. [diakses pada tanggal 9 April 2016].
19. Tuberculosis Coalition for Technical Assistance. Tuberculosis Coalition for Technical
Assistance, International Standards for Tuberculosis Care (ISTC) Edisi Kedua. 2009.
The Hague.
20. Departemen Kesehatan RI. 2009. Modul kolaborasi Tb-HIV. Jakarta: Direktorat
Jendral Pengendalian Penyakit dan Penyehatan Lingkungan Depkes RI.
21. World Health Organization. 2004. Tb-HIV a clinical manual Edisi kedua. Geneva:
WHO.
22. Departemen Kesehatan RI. 2009. Pedoman Nasional Terapi Antiretroviral Edisi
Kedua. Jakarta: Direktorat Jendral Pengendalian Penyakit dan Penyehatan
Lingkungan Depkes RI.
23. Handayani, S. 2002. Respon Imunitas Seluler Pada Infeksi Tuberkulosis Paru.
Jakarta: Cermin Dunia Kedokteran. 2002; 137:34-37.
24. Departemen Kesehatan RI. 2007. Kebijakan Nasional Kolaborasi Tb/HIV. Jakarta:
Depkes RI.
25. World Health Organization. 2006. Tuberculosis infection control in the era of
expanding HIV care and treatment. Geneva: WHO.
26. Kelompok Kerja Tb-HIV Tingkat Pusat. 2003. Prosedur Tetap Pencegahan dan
Pengobatan Tuberkulosis pada Orang dengan HIV/AIDS. Jakarta: Depkes RI.
27. Departemen Kesehatan RI. 2007. Pedoman Nasional Penanggulangan Tuberkulosis
Edisi kedua. Jakarta: Depkes RI.
28. Burman Wj, Jones BE. 2001. Treatment of HIV-related Tuberculosis in the Era of
Effective Antiretroviral Theraphy. Am J Respir Crit Care Med. 2001; 164:7-12.
29. Departemen Kesehatan RI. 2009. Pedoman Nasional Terapi Antiretroviral. Jakarta:
Direktorat Jendral Pengendalian Penyakit dan Penyehatan Lingkungan Depkes RI.
30. World Health Organization. 2006. Improving the Diagnosis and Treatment of Smearnegative Pulmonary and Extrapulmonary Tuberculosis among Adults and
Adolescents. Geneva: WHO.
31. World Health Organization. 2010. Antiretroviral Theraphy for HIV Infection in Adults
and Adolescents Recommendations for a Public Health Approach. Geneva: WHO.

35

32. Piscitelli SC, Gallicano ED. 2001. Interactions among Drugs for HIV and
Opportunistic Infections. N Eng J Med 2001; 344 (13): 984-996.
33. National Center for HIV/AIDS, Viral Hepatitis, STD, and Tb Prevention Division of
Tuberculosis Elimination. 2007. Managing Drug Interactions in the Treatment of
HIV-realted Tuberculosis. Atlanta: CDC.
34. Carr A, Cooper DA. 2000. Adverser Effects of Antiretroviral Theraphy. Lancet 2000;
356: 1423-30.
35. Montessori V, Press N, Harris M, Akagi L, Montaner JS. 2004. Adverse Effects of
Antiretroviral Theraphy for HIV Infection. CMAJ 2004; 170 (2): 229-38.
36. World Health Organization. 2007. Prioritizing Second-line Antiretroviral Drugs for
Adults and Adolescents: Public Health Approach. Geneva: WHO.
37. Clavel F and Hance AJ. 2004. Medical Progress HIV Drug Resistance. N Engl J Med
2004; 350:1023-35.
38. Feirer J. 2006. MDR-TB and HIV : The Perfect Storm? Editorial. Am J Trop Med
Hyg 2006; 75(6):1025-1026.
39. Anonym. 2010. Laju HIV/AIDS Indonesia Tercepat di Asia. Dapat diunduh pada:
http://www.aidsindonesia.or.id/lajuhivaids-indonesia-tercepat-di-asia.html.
pada tanggal 9 April 2016].

[diakses